Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (Q6)Aug 31, 2025 | (FY)Feb 28, 2025 | (Q6)Aug 31, 2024 | (FY)Feb 29, 2024 | (Q6)Aug 31, 2023 | (FY)Feb 28, 2023 | (Q6)Aug 31, 2022 | (FY)Feb 28, 2022 | (Q6)Aug 31, 2021 | (FY)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 111.79%8.21M | 180.57%9.56M | 12.45%3.88M | -60.13%3.41M | 28.76%3.45M | 6,962.81%8.55M | -1.25%2.68M | 103.68%121K | 162.14%2.71M | -134.82%-3.29M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 31.80%-429K | -24.28%-1.08M | -64.66%-629K | -149.71%-869K | -396.10%-382K | -80.31%-348K | -168.75%-77K | -141.25%-193K | 660.00%112K | -53.85%-80K |
| Interest expense - adjustment | 80.00%9K | 25.00%10K | 150.00%5K | 14.29%8K | -60.00%2K | 16.67%7K | --5K | --6K | ---- | ---- |
| Impairment and provisions: | --406K | 462.50%406K | ---- | -109.15%-112K | --107K | 135.38%1.22M | ---- | -66.62%520K | ---- | 251.69%1.56M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 265.18%185K | ---- | ---112K |
| -Impairment of trade receivables (reversal) | ---356K | -161.49%-356K | ---- | 57,800.00%579K | ---2K | -99.26%1K | ---- | 104.55%135K | ---- | 11.86%66K |
| -Other impairments and provisions | --762K | 210.27%762K | ---- | -156.50%-691K | --109K | 511.50%1.22M | ---- | -87.53%200K | ---- | 317.71%1.6M |
| Revaluation surplus: | ---23K | -126.67%-68K | ---- | ---30K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---23K | -126.67%-68K | ---- | ---30K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | -150.00%-1K | 104.55%4K | 140.00%2K | -450.00%-88K | 0.00%-5K | 87.88%-16K | 92.42%-5K | ---132K | ---66K | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---66K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -150.00%-1K | 104.55%4K | 140.00%2K | -450.00%-88K | 0.00%-5K | 75.76%-16K | 92.42%-5K | ---66K | ---66K | ---- |
| Depreciation and amortization: | 11.99%439K | 16.57%788K | 20.99%392K | -1.31%676K | -3.57%324K | 12.48%685K | 156.49%336K | -49.46%609K | -53.38%131K | 121.51%1.21M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --647K |
| Exchange Loss (gain) | -64.86%-455K | 200.00%1K | -1,825.00%-276K | 99.23%-1K | --16K | -182.28%-130K | ---- | 139.21%158K | ---- | -2,138.89%-403K |
| Special items | ---- | ---- | ---- | --7K | ---- | ---- | ---- | -17,225.00%-685K | ---- | --4K |
| Adjustment items | ---- | ---- | ---36K | ---- | ---- | ---- | ---- | ---- | ---94K | ---- |
| Operating profit before the change of operating capital | 144.60%8.16M | 220.88%9.62M | -4.99%3.33M | -69.92%3M | 19.52%3.51M | 2,367.33%9.97M | 5.08%2.94M | 140.24%404K | 168.13%2.79M | -109.65%-1M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 95.48%-18K | -1,497.30%-517K | -1,758.33%-398K | 317.65%37K | 1,300.00%24K | -153.13%-17K | -105.56%-2K | 138.10%32K | --36K | ---84K |
| Accounts receivable (increase)decrease | 432.57%15.8M | -368.21%-14.15M | -85.98%-4.75M | -299.41%-3.02M | -328.04%-2.55M | 130.13%1.52M | 308.57%1.12M | -7,840.00%-5.03M | -111.94%-537K | 104.70%65K |
| Accounts payable increase (decrease) | -35.01%8.4M | -0.98%18.06M | 227.32%12.93M | 573.24%18.24M | 183.08%3.95M | -66.03%2.71M | -1,007.06%-4.75M | 125.89%7.97M | 113.68%524K | 502.05%3.53M |
| prepayments (increase)decrease | 473.72%583K | -41.75%-1.62M | -21.88%-156K | -522.51%-1.15M | -121.12%-128K | -79.99%271K | -30.74%606K | 194.22%1.35M | 128.21%875K | -501.26%-1.44M |
| Special items for working capital changes | 72.52%-2.89M | -3,733.48%-8.7M | -75.60%-10.51M | 97.41%-227K | -169.64%-5.98M | -59.53%-8.77M | 403.25%8.59M | -1,470.32%-5.5M | -157.06%-2.83M | 107.98%401K |
| Cash from business operations | 6,573.33%30.03M | -84.10%2.68M | 138.04%450K | 197.10%16.88M | -113.92%-1.18M | 845.54%5.68M | 889.29%8.5M | -151.80%-762K | 154.71%859K | -48.94%1.47M |
| Other taxs | -152.30%-878K | 63.53%-662K | 60.72%-348K | -485.48%-1.82M | -712.84%-886K | -93.75%-310K | -78.69%-109K | 95.21%-160K | 87.90%-61K | -408.37%-3.34M |
| Interest received - operating | 135.79%705K | 216.14%705K | 4,883.33%299K | 99.11%223K | -64.71%6K | 558.82%112K | 0.00%17K | 0.00%17K | 54.55%17K | -59.52%17K |
| Special items of business | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | ---- | ---- | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 7,345.64%29.86M | -82.16%2.73M | 119.44%401K | 178.79%15.29M | -124.54%-2.06M | 705.86%5.48M | 931.41%8.41M | 51.13%-905K | 139.51%815K | -181.73%-1.85M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 76.99%423K | 23.46%542K | 856.00%239K | 501.37%439K | -58.33%25K | -58.52%73K | -36.84%60K | 179.37%176K | 955.56%95K | 530.00%63K |
| Decrease in deposits (increase) | ---16.88M | -82.72%650K | --0 | 184.18%3.76M | --0 | -250.17%-4.47M | ---706K | 115.63%2.98M | ---- | -2,092.05%-19.04M |
| Sale of fixed assets | 5,500.00%56K | -97.06%4K | -95.00%1K | 518.18%136K | 300.00%20K | -66.67%22K | -92.42%5K | --66K | --66K | ---- |
| Purchase of fixed assets | -532.61%-291K | 60.96%-340K | 67.83%-46K | -162.35%-871K | -120.00%-143K | 35.78%-332K | 89.18%-65K | -261.54%-517K | -567.78%-601K | 78.59%-143K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.02%-148K | ---- | ---2.12M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --685K | ---- | ---- |
| Cash on investment | ---500K | ---- | ---- | ---2M | ---1M | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -8,959.28%-17.19M | -41.61%856K | 117.67%194K | 131.15%1.47M | -55.52%-1.1M | -245.38%-4.71M | -60.45%-706K | 115.24%3.24M | -443.21%-440K | -6,537.27%-21.24M |
| Net cash before financing | 2,029.41%12.67M | -78.61%3.58M | 118.82%595K | 2,055.98%16.75M | -141.05%-3.16M | -66.68%777K | 1,953.33%7.7M | 110.10%2.33M | 117.49%375K | -989.64%-23.1M |
| Cash flow from financing activities | ||||||||||
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 600.00%14K |
| Net cash from financing operations | -35.80%-110K | -77.42%-165K | -138.24%-81K | 7.92%-93K | 32.00%-34K | -94.23%-101K | ---50K | -471.43%-52K | ---- | -99.92%14K |
| Effect of rate | -550.00%-27K | --88K | --6K | ---- | ---- | 1,680.00%89K | 217.96%243K | 103.31%5K | 34.39%-206K | -139.32%-151K |
| Net Cash | 2,343.58%12.56M | -79.48%3.42M | 116.09%514K | 2,364.35%16.66M | -141.76%-3.2M | -70.35%676K | 1,940.00%7.65M | 109.88%2.28M | 117.47%375K | -213.23%-23.08M |
| Begining period cash | 13.20%30.07M | 168.17%26.57M | 168.17%26.57M | 8.37%9.91M | 8.37%9.91M | 33.33%9.14M | -64.71%9.14M | -77.21%6.86M | -13.92%25.9M | 222.87%30.09M |
| Cash at the end | 57.30%42.6M | 13.20%30.07M | 303.59%27.09M | 168.17%26.57M | -60.60%6.71M | 8.37%9.91M | -34.66%17.03M | 33.33%9.14M | -5.64%26.07M | -77.21%6.86M |
| Cash balance analysis | ||||||||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.